William "Ben" B. Jones is the Senior Vice President of Pharmaceutical Development at Corvus Pharmaceuticals, a company he joined near its inception. He leads cross-functional teams in developing oncology drugs, drawing on his PhD and extensive experience in regulatory affairs, quality assurance, and project management to bring novel cancer therapies from concept to market.
His career is distinguished by his leadership roles in the development of three first-in-class, commercially successful oncology drugs: ibrutinib (Imbruvica®), vemurafenib (Zelboraf®), and isatuximab (Sarclisa®).
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.